CHORDOMA FOUNDATION
EIN: 20-8423943Durham, NCZIP: 27702
H30 - Medical Research501(c)(3)
Mission
THE MISSION OF THE CHORDOMA FOUNDATION IS TO IMPROVE THE LIVES OF THOSE AFFECTED BY CHORDOMA AND LEAD THE SEARCH FOR A CURE.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $7.4M | $0 | $11M |
Compensation
Similar Organizations
PROJECT DS INC
$5M revenueMorrisville, NC
Same sector (H30)Comparable revenue ($5M vs $7.4M)Same state (North Carolina)Similar size (17 vs 17 executives)
FOR PETE'S SAKE CANCER RESPITE
$4.7M revenuePlymouth Meeting, PA
Same sector (H30)Comparable revenue ($4.7M vs $7.4M)Similar median compensation ($128k vs $145k)Similar size (19 vs 17 executives)
ADVANCED MEDICAL RESEARCH FOUNDATION
$4M revenueChestnut Hill, MA
Same sector (H30)Comparable revenue ($4M vs $7.4M)Similar median compensation ($151k vs $145k)
Pediatric Brain Tumor Foundation of the United States Inc
$5M revenueWinston Salem, NC
Similar sector (H)Comparable revenue ($5M vs $7.4M)Same state (North Carolina)Similar median compensation ($128k vs $145k)
LANIADO DEVELOPMENT FUND INC
$4.7M revenueMonsey, NY
Same sector (H30)Comparable revenue ($4.7M vs $7.4M)
CEREBRAL PALSY FOUNDATION INC
$4.7M revenueNew York, NY
Similar sector (H)Comparable revenue ($4.7M vs $7.4M)Similar median compensation ($145k vs $145k)Similar size (17 vs 17 executives)
AMERICAN BURN ASSOCIATION
$5.3M revenueChicago, IL
Similar sector (H)Comparable revenue ($5.3M vs $7.4M)Similar median compensation ($129k vs $145k)
HEARING HEALTH FOUNDATION
$5.3M revenueNew York, NY
Similar sector (H)Comparable revenue ($5.3M vs $7.4M)Similar median compensation ($134k vs $145k)
Maine Cancer Foundation
$3.8M revenueFalmouth, ME
Similar sector (H)Comparable revenue ($3.8M vs $7.4M)Comparable compensation levelsSimilar size (18 vs 17 executives)
ARTHRITIS NATIONAL RESEARCH FOUNDATION
$3.8M revenueIrvine, CA
Similar sector (H)Comparable revenue ($3.8M vs $7.4M)Comparable compensation levelsSimilar size (16 vs 17 executives)
Data from IRS Form 990 filings (2023).